Navigation Links
European Centre for Modern Drug Discovery Established in Hamburg
Date:9/3/2007

HAMBURG, Germany, September 3 /PRNewswire-FirstCall/ -- Hamburg is on its way to becoming a leading hub of Europe's academic drug discovery, with the northern German city's town hall today announcing the foundation of European ScreeningPort GmbH, a company that will run a state-of-the-art drug discovery service centre. European ScreeningPort is being established with the support of the German Federal Ministry of Education and Research, the Free and Hanseatic City of Hamburg, Evotec AG and Norgenta, the north German life science agency. Although still in an early phase, the project has already raised more than EUR 7 million in financing.

Hamburg's new European ScreeningPort will build upon research results generated in academia. It will enable a more systematic and efficient search for promising new compounds which can subsequently be further developed. Both Evotec AG and the City of Hamburg have invested into the newly founded company, which will be run as a public private partnership. This novel concept in advancing drug discovery will also be supported with considerable funds from the German Federal Ministry of Education and Research.

ScreeningPort provides the missing link in Europe between academic research and the pharmaceutical industry. The research centre will accelerate translating promising results generated in basic research on the causes of diseases into new therapeutics. ScreeningPort will act as a service provider that enables academic research institutes to access its state-of-the-art technology, its vast amount of chemical compounds as well as its sample and data processing capabilities. New therapeutic concepts developed at universities can, in future, undergo the same standardised, more efficient and thus more cost-effective development processes that have, until now, been available only to industry. Pharmaceutical and biotech companies, for their part, can benefit from the research results generated at ScreeningPort and thus complement their own drug research.

ScreeningPort is planned to be at the heart of an international network. Although it is still at an early stage, a number of European research institutes have already been tied in. Among others, the Swiss Federal Institute of Technology (ETH Zurich) and the Vienna-based Institute of Molecular Biotechnology of the Austrian Academy of Sciences have signed letters of intent.

The ScreeningPort project was initiated by Evotec AG, a leading drug discovery and development company, bringing in its extensive expertise. It was implemented by Norgenta GmbH, the north German life science agency that promotes the structural development of life sciences in the federal states of Hamburg and Schleswig-Holstein.

Other partners are also raring to go, such as c.a.r.u.s. IT AG, a company specialised in high-performance data management solutions for life sciences.

Statements:

Thomas Rachel, member of the German federal parliament and parliamentary secretary of state at the German Federal Ministry of Education and Research:

"ScreeningPort is an important element to close the gap between basic research and the commercial development of new therapeutics. Therefore the Federal Ministry of Education and Research has decided to financially support, as part of its Pharmaceuticals Initiative for Germany campaign, the establishment of the ScreeningPort and initial pilot projects in screening. Total funding of more than EUR 800 million will be provided by 2011 under this initiative which is aimed at accelerating the development of innovative therapeutics for patients."

Senator Gunnar Uldall, Head of the State Ministry of Economic and Labour Affairs, City of Hamburg:

"By funding and implementing this project, we continue and further complement our successful cluster policy for the life sciences in northern Germany. The new ScreeningPort provides Hamburg with the opportunity to become a leading European centre of modern pharmaceutical research."

Senator Jorg Drager, Head of the State Ministry of Science and Research, City of Hamburg:

"Establishing the European ScreeningPort in Hamburg is an important milestone in the development of the life science cluster in northern Germany. Together with our partners, the Federal Ministry of Education and Research and Evotec AG, we are building a state-of-the-art research infrastructure from which universities in Germany and beyond will be able to benefit. Having this infrastructure for scientist to develop drug candidates for innovative therapeutics in place is a huge success for our scientific region and proof of the good work conducted by Norgenta, the cluster agency of Hamburg and Schleswig-Holstein."

Jorn Aldag, President & Chief Executive Officer of Evotec AG:

"We know from our many years of experience as a leading European partner in drug discovery for pharmaceutical and biotech companies worldwide, and from our own research on diseases of the Central Nervous System that academic research generates a plethora of excellent scientific ideas that require an industrial environment for further development. The initial step in this development is the search to identify biologically active chemical compounds. The European ScreeningPort provides us with the link that translates scientific discoveries into results that pharmaceutical and biotechnological companies, such as Evotec, can build upon."

Dr Kathrin Adlkofer, Managing Director of the North German Life Science Agency Norgenta:

"Our main objective is to bring together existing excellence in science and business. ScreeningPort will see a unique network of partners in academia and industry who will mutually be able to benefit from pooling their expertise in medical science, technological know-how and industrial performance."

Contact:

Press office of the German Federal Ministry of Education and Research

Katrin Hagedorn

P +49-30-1857-5051

katrin.hagedorn@bmbf.bund.de

Evotec AG

Anne Hennecke

P +49-40-56-081-286

anne.hennecke@evotec.com

Norgenta GmbH

Ina Akkerman

P +49-40-471-96-418

ina.akkerman@norgenta.de

Press office of the State Ministry of Economic and Labour Affairs, Free

and Hanseatic City of Hamburg

Arne Maydell

P +49-40-428-41-3015

arne.maydell@bwa.hamburg.de

Press office of the State Ministry of Science and Research, Free and

Hanseatic City of Hamburg

Janis Eitner

P +49-40-428-63-23-22

pressestelle@bwf.hamburg.de

c.a.r.u.s. IT AG

Matthias Rath

P +49-40-51435-2410

contact.presse@carus-it.com


'/>"/>
SOURCE Evotec AG
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Mirus granted European patent for gene therapy
2. Info security group announces first Eastern European chapter
3. EMD Biosciences partners with European biotech company
4. Third Wave lands European distribution deal, reports high earnings
5. The combination of monolithic columns and modern HPLC/MS/MS instrumentation for high chromatographic throughput and sensitive detection of beta-agonists
6. A (modern) Tale of Two Cities: Milwaukee and Madison inch together
7. Building the modern public-purpose university should be UW Systems goal
8. Modernizing the tax code can make Wisconsin tech businesses more competitive
9. SEESNP DISCOVERY
10. siRNA screening of the cell cycle with two dynamic GFP sensors (from Discovery Matters Issue 1, July 2005)
11. Exploiting the Life Science Data Explosion to Speed New Drug Discovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... The Blavatnik ... Winners and six Finalists of the 2017 Blavatnik Regional Awards for Young Scientists. ... Foundation and administered by the New York Academy of Sciences to honor the ...
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS ... the addition of its newest module, US Hemostats & Sealants. , SmartTRAK’s US ... absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants used in surgical applications. ...
(Date:10/11/2017)... ... October 11, 2017 , ... At its ... announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief research scientist of ... been selected for membership in ARCS Alumni Hall of Fame . ASTER ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit ... 7th and 8th June 2018 in San Francisco, CA. The Summit brings together current ... several distinguished CEOs, board directors and government officials from around the world to address ...
Breaking Biology Technology:
(Date:5/16/2017)... TEANECK, N.J. , May 16, 2017  Veratad ... leading provider of online age and identity verification solutions, ... the K(NO)W Identity Conference 2017, May 15 thru May ... Ronald Regan Building and International Trade Center. ... across the globe and in today,s quickly evolving digital ...
(Date:4/24/2017)... -- Janice Kephart , former 9/11 Commission ... LLP (IdSP) , today issues the following statement: ... 6, 2017 Executive Order: Protecting the Nation ... instilled with greater confidence, enabling the reactivation of ... are suspended by until at least July 2017). ...
(Date:4/17/2017)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... 2016 Annual Report on Form 10-K on Thursday April 13, 2017 ... ... Investor Relations section of the Company,s website at http://www.nxt-id.com  under ... http://www.sec.gov . 2016 Year Highlights: ...
Breaking Biology News(10 mins):